NIH-funded research R01 grant

Understanding how gut bacteria process sugars to improve health

Official title: Gatekeeping glycan metabolism in the human gut microbiome

Funded at Emory University · NIH-10898926 · Data updated 2026-11-12

This study is looking at how the bacteria in our gut use sugars from our food and body, with the goal of finding new ways to improve gut health and help with various health issues, so you might get helpful tips for your diet or treatments to support a healthier gut.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 15, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$371,991
NIH project number5R01GM148075-02
Project IDNIH-10898926 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing gastrointestinal disorders or those interested in improving their gut health through dietary changes.

Less likely to help

Patients with stable gut health and no gastrointestinal issues may not see direct benefits from this research.

What this research studies

This research investigates the ways in which bacteria in the human gut metabolize glycans, which are complex sugars derived from our diet and body. By exploring these metabolic processes, the research aims to identify new therapeutic strategies to alter the gut microbiome's composition, potentially addressing various health issues. The study will involve analyzing how different bacteria compete for these sugars and how this competition affects overall gut health and disease states. Patients may benefit from insights that could lead to dietary recommendations or treatments that promote a healthier gut microbiome.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance gut health and prevent or manage diseases linked to gut microbiota imbalances.

How similar studies have gone: Previous research has shown promising results in manipulating gut microbiota through dietary interventions, suggesting that this approach may be viable.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Sundberg, Eric John — Emory University
  • Study coordinator: Sundberg, Eric John

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.